SLN
SLN (sarcolipin) is a small proteolipid of the sarcoplasmic reticulum membrane that regulates SERCA Ca(2+)-ATPases in muscle cells. It modulates calcium re-uptake during muscle relaxation and is required for muscle-based, non-shivering thermogenesis. Browse Assay Genie's current range of SLN research reagents below, or read on for the biology behind the target.
Sarcoplasmic reticulum Ca(2+)-ATPases (SERCAs) are transmembrane proteins that catalyse the ATP-dependent transport of Ca(2+) from the cytosol into the lumen of the sarcoplasmic reticulum in muscle cells. SLN is a small proteolipid that regulates several of these pumps. It interacts with the Ca(2+)-ATPases and reversibly inhibits ATP2A1/SERCA1 and ATP2A2/SERCA2 by decreasing the apparent affinity of the ATPase for Ca(2+). It also inhibits ATP2A3/SERCA3.
The effect of SLN is on calcium accumulation rather than on catalysis. According to the NCBI Gene summary, the protein reduces the accumulation of Ca(2+) in the sarcoplasmic reticulum without affecting the rate of ATP hydrolysis. In this way SLN modulates calcium re-uptake during muscle relaxation and plays an important role in calcium homeostasis in muscle. It is also required for muscle-based, non-shivering thermogenesis.
SLN is a transmembrane protein located in the sarcoplasmic reticulum membrane and the endoplasmic reticulum membrane. It belongs to the sarcolipin family and is classified by HGNC in the regulins gene group. Researchers studying the human SLN gene or SLN protein will find mouse and rat orthologs, both named Sln. Alternative designations listed for the gene include MGC12301, MGC125854 and MGC125855.
SLN lowers the apparent Ca(2+) affinity of SERCA pumps, making it a focus for work on calcium re-uptake during muscle relaxation.
SLN plays an important role in calcium homeostasis in muscle, relevant to how sarcoplasmic reticulum calcium accumulation is controlled.
SLN is required for muscle-based, non-shivering thermogenesis, linking this small proteolipid to muscle heat production.
SLN inhibits SERCA1, SERCA2 and SERCA3, providing a model for studying regulin control of Ca(2+)-ATPases.
SLN reversibly inhibits SERCA1 and SERCA2, and also SERCA3, by decreasing the apparent affinity of the ATPase for Ca(2+). It modulates calcium re-uptake during muscle relaxation, contributes to calcium homeostasis in muscle and is required for muscle-based, non-shivering thermogenesis.
SLN stands for sarcolipin. Aliases listed for the gene are MGC12301, MGC125854 and MGC125855. HGNC places it in the regulins gene group, and UniProt assigns it to the sarcolipin family, which reflects its role as a small regulatory proteolipid.
Mouse and rat both have an ortholog named Sln, so rodent systems can be used to study its function. Whether a given reagent recognises these orthologs varies, so check the datasheet of any product for its validated reactivity.
SERCA Ca(2+)-ATPases and other regulins involved in sarcoplasmic reticulum calcium handling.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00631; product specifications from Assay Genie datasheets.